Arca
Skip to content
Tools
Tools

HMGCR: 3-hydroxy-3-methylglutaryl-coenzyme A reductase

Catalyzes the conversion of (3S)-hydroxy-3-methylglutaryl-CoA (HMG-CoA) to mevalonic acid, the rate-limiting step in the synthesis of cholesterol and other isoprenoids, thus plays a critical role in cellular cholesterol homeostasis.

  • Drugs that act on it: 8
  • Approved: 8
  • In phases 1 to 3: 0
  • Sponsors: 8

Who is on it, and how far along

Every drug ChEMBL records acting on HMGCR, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 8

Approved8

  • Atorvastatin
  • Rosuvastatin
  • Simvastatin
  • Lovastatin
  • Pitavastatin
  • Pravastatin
  • Fluvastatin
  • Cerivastatin

Phase 30

    Phase 20

      Phase 10

        Sponsors

        Drugs on this target per company: the US application holder, else the industry sponsor leading the most of its trials.

        The landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. All act as: HMG-CoA reductase inhibitor.
        AtorvastatinApprovedViatrisSmall moleculeInhibitor150
        RosuvastatinApprovedAstraZeneca PharmaceuticalsSmall moleculeInhibitor119
        SimvastatinApprovedOrganonSmall moleculeInhibitor53
        LovastatinApprovedMerck & Co. (MSD)Small moleculeInhibitor51
        PitavastatinApprovedViiV HealthcareSmall moleculeInhibitor26
        PravastatinApprovedBristol-Myers SquibbSmall moleculeInhibitor16
        FluvastatinApprovedNovartis PharmaceuticalsSmall moleculeInhibitor8
        CerivastatinWithdrawnApprovedBayerSmall moleculeInhibitor0

        Open trials

        The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 34 in all, from ClinicalTrials.gov.
        Real-World Study Comparing PCSK9 Monoclonal Antibody With Cholesterol Absorption Inhibitors in Patients With ASCVD for Secondary PreventionAtorvastatin, Fluvastatin, Lovastatin, Pravastatin, Rosuvastatin, Simvastatin, Pitavastatin—Active, not recruitingXin LiNov 16, 2026
        An Evaluation of the Potential for VH4011499 Drug-drug-interactionsRosuvastatin, PitavastatinPhase 1Not yet recruitingViiV HealthcareNov 16, 2026
        Drug-coated Balloon Angioplasty For Ischemic Stroke Within 30 Days Caused By Intracranial Arterial Stenosis ( BASIS-2 )AtorvastatinNot applicableNot yet recruitingBeijing Tiantan HospitalNov 12, 2026
        A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin, and Placebo on LDL-C in LLT-naïve PatientsRosuvastatinPhase 3Not yet recruitingAstraZenecaNov 12, 2026
        Study of SIM0518 in Participants With ALK-Positive or ROS1-Positive Locally Advanced or Metastatic Non-Small Cell Lung CancerRosuvastatinPhase 1Not yet recruitingJiangsu Simcere Pharmaceutical Co., Ltd.Nov 3, 2026
        Upfront Lipid-Lowering Therapy With Statins Combined With Hybutimibe in Patients With Acute Ischemic Stroke or Transient Ischemic Attack.AtorvastatinPhase 3Not yet recruitingFirst Affiliated Hospital of Wannan Medical CollegeNov 2, 2026
        Effectiveness and Tolerability of a Treat-to-Target Versus Fixed-Dose Statin Strategy in Patients With Atherosclerotic Cardiovascular DiseaseAtorvastatin, RosuvastatinPhase 4Not yet recruitingRehman Medical Institute - RMINov 2, 2026
        A Study on the Safety and Clinical Efficacy of Guominkang in the Treatment of Diabetic Kidney DiseaseAtorvastatin, Fluvastatin, Pravastatin, SimvastatinPhase 2Active, not recruitingBeijing University of Chinese MedicineOct 30, 2026
        Clinical Evaluation of the Safety and Efficacy of "Buyan Huan Wu Tang" Combined With Atorvastatin in the Treatment of Atypical PneumoniaAtorvastatinEarly phase 1Enrolling by invitationThe First Affiliated Hospital with Nanjing Medical UniversityOct 30, 2026
        Clinical Safety and Efficacy Evaluation of the Blood-cooling and Stasis-removing Formula as an Adjunct to Atorvastatin in the Treatment of Hemorrhagic Moyamoya Disease.AtorvastatinEarly phase 1Enrolling by invitationThe First Affiliated Hospital with Nanjing Medical UniversityOct 26, 2026
        Comparing Inclisiran Versus Statin for Primary AldosteronismAtorvastatin, Fluvastatin, Lovastatin, Simvastatin, PitavastatinNot applicableRecruitingThird Military Medical UniversityOct 21, 2026
        A Multiple-dose Study Investigating the Drug-drug Interaction Potential and QTc Effects of Fosmanogepix in Healthy Adult SubjectsRosuvastatinPhase 1RecruitingBasilea PharmaceuticaOct 19, 2026
        A Phase I Study of the Interaction of D-2570 With Other Drugs in Healthy AdultsRosuvastatinPhase 1Not yet recruitingInventisBio Co., LtdOct 15, 2026
        Feasibility of Combination Therapy With Low-dose Statin and Ezetimibe in Patients With Minimal Subclinical AtherosclerosisRosuvastatin, PitavastatinPhase 4Not yet recruitingYonsei UniversityOct 13, 2026
        VISTA: Valproic Acid, Irinotecan, and Simvastatin for Recurrent GliomaLovastatin, SimvastatinPhase 2RecruitingInova Health Care ServicesSep 21, 2026
        A Phase 1 Clinical Trial to Evaluate the Safety and the Pharmacokinetic Drug-Drug Interaction Between HUC2A-752-A and HUC2A-752-B in Healthy AdultsPitavastatinPhase 1Not yet recruitingHuons Co., Ltd.Aug 25, 2026
        Precision Medicine Adaptive Network Platform Trial in Hypoxemic Acute Respiratory FailureLovastatin, SimvastatinPhase 2Not yet recruitingUniversity of Colorado, DenverAug 21, 2026
        Safety Evaluation Study of Pitavastatin PLGA Nano-particle for Retinitis PigmentosaPitavastatinPhase 1RecruitingKyushu UniversityAug 19, 2026
        Study of ECC4703 With Sulfasalazine and PitavastatinPitavastatinPhase 1RecruitingEccogeneJul 24, 2026
        Immunotheray Combined With Simvastatin and Target Therapy and Chemotharepy for Advanced Colorectal CancerSimvastatinPhase 2RecruitingThe First Affiliated Hospital with Nanjing Medical UniversityJul 22, 2026
        Aggressive Lipid Lowering Therapy in ICI-Treated MelanomaLovastatin, Pravastatin, SimvastatinNot applicableRecruitingUniversity of Colorado, DenverJul 15, 2026
        New Topical Treatment in Patchy Alopecia AreataLovastatin, SimvastatinNot applicableNot yet recruitingSohag UniversityJul 10, 2026
        Topical 2% Simvastatin for Xanthelasma PalpebrarumLovastatinPhase 2Not yet recruitingKlira SkinJun 23, 2026
        RESTAGE (REpurposing STAtins to Improve Outcomes in GastroEsophageal Cancer) TrialLovastatinPhase 2Not yet recruitingMcGill University Health Centre/Research Institute of the McGill University Health CentreJun 4, 2026
        Livalozet Versus High-intensity Statin in Older Patients With Coronary Artery Disease Undergoing Percutaneous Coronary InterventionPitavastatinNot applicableNot yet recruitingSamsung Medical CenterJun 4, 2026
        Novel Treatment of Radiation Associated Dysphagia With StatinsPravastatinPhase 2RecruitingPeter MacCallum Cancer Centre, AustraliaOct 20, 2025
        Statin Intervention for Severe Early-Onset Placental Insufficiency. (STATIN-PRE Trial)PravastatinPhase 2RecruitingFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauAug 1, 2025
        Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)PravastatinPhase 2RecruitingM.D. Anderson Cancer CenterApr 6, 2025
        Randomized Comparison of Morning Versus Bedtime Administration of Statins: A Cardiovascular Circadian Chronotherapy (C3) TrialPravastatinPhase 4Not yet recruitingTor Biering-SørensenMar 4, 2025
        Bioequivalence Study of Fluvastatin Sodium Extended Release Tablets in Healthy ParticipantsFluvastatinPhase 1Not yet recruitingShenzhen Salubris Pharmaceuticals Co., Ltd.Feb 17, 2025
        Statins in Frail Older Patients with Ischemic Stroke or Transient Ischemic Attack - the Prospective Cohort StudyFluvastatin, Pravastatin—RecruitingAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Jan 21, 2025
        StAtins in Frail OldEr Patients with Ischemic Stroke or Transient Ischemic Attack - the Randomized Controlled TrialFluvastatinPhase 4Not yet recruitingProf. dr. Nathalie van der VeldeJan 21, 2025
        A Trial of HRS-2189 in Combination With Fluvastatin±HRS-6209, or HRS-8080±HRS-6209, or HRS-6209+HRS-1358 in Breast Cancer PatientsFluvastatinPhase 1 / Phase 2RecruitingShandong Suncadia Medicine Co., Ltd.Nov 7, 2024
        LATAM LOWERS LDL-CFluvastatinPhase 4RecruitingNovartis PharmaceuticalsJul 15, 2024

        Diseases most associated with it

        Open Targets association score, 0 to 1; all associations
        Coronary artery disorder
        0.72
        Stroke disorder
        0.69
        Inherited lipid metabolism disorder
        0.68
        Cardiovascular disorder
        0.67
        Muscular dystrophy, limb-girdle, autosomal recessive 28
        0.66
        Type 2 diabetes mellitus
        0.65
        Hypertensive disorder
        0.60

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL402, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-18. Gene name, function (UniProt P04035, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

        Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.